The demonstration represents another development milestone in the Company’s development of quantum-enabled platform for high-dimensional clinical ...
TEL AVIV, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that ...
SciSparc Ltd. , through its majority-owned subsidiary NeuroThera Labs , announced that subsidiary CliniQuantum reported successful quantum-enabled analysis of billions of gene com ...
Pasqal (PSQL) stock rose after StoneX set a $15 price target, implying nearly 140% upside for the quantum computing company.
About NeuroThera Labs Inc. NeuroThera is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions ...
The demonstration represents another development milestone in CliniQuantum’s development of quantum-enabled platform for high-dimensional clinical data analysis The evaluation used a real clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results